BIO-TECHNE CORP (TECH) Fundamental Analysis & Valuation

NASDAQ:TECH • US09073M1045

Current stock price

50.95 USD
-1.75 (-3.32%)
At close:
50.95 USD
0 (0%)
After Hours:

This TECH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. TECH Profitability Analysis

1.1 Basic Checks

  • TECH had positive earnings in the past year.
  • TECH had a positive operating cash flow in the past year.
  • In the past 5 years TECH has always been profitable.
  • In the past 5 years TECH always reported a positive cash flow from operatings.
TECH Yearly Net Income VS EBIT VS OCF VS FCFTECH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • With a decent Return On Assets value of 3.17%, TECH is doing good in the industry, outperforming 73.21% of the companies in the same industry.
  • TECH's Return On Equity of 3.98% is fine compared to the rest of the industry. TECH outperforms 73.21% of its industry peers.
  • TECH has a Return On Invested Capital of 9.52%. This is amongst the best in the industry. TECH outperforms 87.50% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for TECH is below the industry average of 12.34%.
  • The last Return On Invested Capital (9.52%) for TECH is above the 3 year average (9.00%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.17%
ROE 3.98%
ROIC 9.52%
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
TECH Yearly ROA, ROE, ROICTECH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • TECH's Profit Margin of 6.58% is fine compared to the rest of the industry. TECH outperforms 69.64% of its industry peers.
  • In the last couple of years the Profit Margin of TECH has declined.
  • The Operating Margin of TECH (22.59%) is better than 92.86% of its industry peers.
  • TECH's Operating Margin has been stable in the last couple of years.
  • TECH has a better Gross Margin (66.60%) than 87.50% of its industry peers.
  • TECH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 22.59%
PM (TTM) 6.58%
GM 66.6%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
TECH Yearly Profit, Operating, Gross MarginsTECH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

8

2. TECH Health Analysis

2.1 Basic Checks

  • TECH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, TECH has less shares outstanding
  • TECH has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, TECH has a worse debt to assets ratio.
TECH Yearly Shares OutstandingTECH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
TECH Yearly Total Debt VS Total AssetsTECH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • TECH has an Altman-Z score of 11.36. This indicates that TECH is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 11.36, TECH belongs to the best of the industry, outperforming 96.43% of the companies in the same industry.
  • The Debt to FCF ratio of TECH is 1.17, which is an excellent value as it means it would take TECH, only 1.17 years of fcf income to pay off all of its debts.
  • TECH's Debt to FCF ratio of 1.17 is amongst the best of the industry. TECH outperforms 91.07% of its industry peers.
  • A Debt/Equity ratio of 0.13 indicates that TECH is not too dependend on debt financing.
  • TECH has a better Debt to Equity ratio (0.13) than 60.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 1.17
Altman-Z 11.36
ROIC/WACC0.87
WACC10.95%
TECH Yearly LT Debt VS Equity VS FCFTECH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • TECH has a Current Ratio of 4.54. This indicates that TECH is financially healthy and has no problem in meeting its short term obligations.
  • TECH has a Current ratio of 4.54. This is in the better half of the industry: TECH outperforms 75.00% of its industry peers.
  • A Quick Ratio of 3.08 indicates that TECH has no problem at all paying its short term obligations.
  • TECH's Quick ratio of 3.08 is fine compared to the rest of the industry. TECH outperforms 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 4.54
Quick Ratio 3.08
TECH Yearly Current Assets VS Current LiabilitesTECH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

5

3. TECH Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 8.84% over the past year.
  • Measured over the past years, TECH shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.25% on average per year.
  • The Revenue has been growing slightly by 1.64% in the past year.
  • Measured over the past years, TECH shows a quite strong growth in Revenue. The Revenue has been growing by 10.55% on average per year.
EPS 1Y (TTM)8.84%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%9.52%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%0.24%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.61% on average over the next years. This is quite good.
  • TECH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.10% yearly.
EPS Next Y5.04%
EPS Next 2Y7.37%
EPS Next 3Y10.09%
EPS Next 5Y8.61%
Revenue Next Year0.73%
Revenue Next 2Y3.52%
Revenue Next 3Y5.54%
Revenue Next 5Y7.1%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TECH Yearly Revenue VS EstimatesTECH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B
TECH Yearly EPS VS EstimatesTECH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

4

4. TECH Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 25.86, which means the current valuation is very expensive for TECH.
  • Compared to the rest of the industry, the Price/Earnings ratio of TECH indicates a somewhat cheap valuation: TECH is cheaper than 71.43% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 24.88, TECH is valued at the same level.
  • Based on the Price/Forward Earnings ratio of 22.90, the valuation of TECH can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of TECH indicates a somewhat cheap valuation: TECH is cheaper than 71.43% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, TECH is valued at the same level.
Industry RankSector Rank
PE 25.86
Fwd PE 22.9
TECH Price Earnings VS Forward Price EarningsTECH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 66.07% of the companies in the same industry are more expensive than TECH, based on the Enterprise Value to EBITDA ratio.
  • 66.07% of the companies in the same industry are more expensive than TECH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 35.74
EV/EBITDA 22.02
TECH Per share dataTECH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • TECH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.13
PEG (5Y)2.3
EPS Next 2Y7.37%
EPS Next 3Y10.09%

4

5. TECH Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.62%, TECH is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.12, TECH pays a better dividend. On top of this TECH pays more dividend than 92.86% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.90, TECH's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.62%

5.2 History

  • The dividend of TECH has a limited annual growth rate of 0.11%.
  • TECH has paid a dividend for at least 10 years, which is a reliable track record.
  • The dividend of TECH decreased recently.
Dividend Growth(5Y)0.11%
Div Incr Years0
Div Non Decr Years1
TECH Yearly Dividends per shareTECH Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0 0 0 0

5.3 Sustainability

  • TECH pays out 62.38% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of TECH is growing, but earnings are growing more, so the dividend growth is sustainable.
DP62.38%
EPS Next 2Y7.37%
EPS Next 3Y10.09%
TECH Yearly Income VS Free CF VS DividendTECH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
TECH Dividend Payout.TECH Dividend Payout, showing the Payout Ratio.TECH Dividend Payout.PayoutRetained Earnings

TECH Fundamentals: All Metrics, Ratios and Statistics

BIO-TECHNE CORP

NASDAQ:TECH (3/27/2026, 4:54:03 PM)

After market: 50.95 0 (0%)

50.95

-1.75 (-3.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-04
Earnings (Next)05-05
Inst Owners113.95%
Inst Owner Change4.01%
Ins Owners0.25%
Ins Owner Change1.57%
Market Cap7.97B
Revenue(TTM)1.22B
Net Income(TTM)79.96M
Analysts80.87
Price Target76.73 (50.6%)
Short Float %6.81%
Short Ratio4.27
Dividend
Industry RankSector Rank
Dividend Yield 0.62%
Yearly Dividend0.32
Dividend Growth(5Y)0.11%
DP62.38%
Div Incr Years0
Div Non Decr Years1
Ex-Date02-13
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.96%
Min EPS beat(2)-2.04%
Max EPS beat(2)3.95%
EPS beat(4)3
Avg EPS beat(4)3.35%
Min EPS beat(4)-2.04%
Max EPS beat(4)7.36%
EPS beat(8)6
Avg EPS beat(8)3.61%
EPS beat(12)6
Avg EPS beat(12)1.11%
EPS beat(16)7
Avg EPS beat(16)-2.33%
Revenue beat(2)0
Avg Revenue beat(2)-1.79%
Min Revenue beat(2)-3.53%
Max Revenue beat(2)-0.04%
Revenue beat(4)0
Avg Revenue beat(4)-1.87%
Min Revenue beat(4)-3.53%
Max Revenue beat(4)-0.04%
Revenue beat(8)3
Avg Revenue beat(8)-0.65%
Revenue beat(12)3
Avg Revenue beat(12)-1.76%
Revenue beat(16)4
Avg Revenue beat(16)-2.17%
PT rev (1m)7.39%
PT rev (3m)7.67%
EPS NQ rev (1m)-0.99%
EPS NQ rev (3m)-4.78%
EPS NY rev (1m)0.37%
EPS NY rev (3m)0.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.44%
Revenue NY rev (1m)0.16%
Revenue NY rev (3m)0.16%
Valuation
Industry RankSector Rank
PE 25.86
Fwd PE 22.9
P/S 6.56
P/FCF 35.74
P/OCF 31.97
P/B 3.96
P/tB 11.46
EV/EBITDA 22.02
EPS(TTM)1.97
EY3.87%
EPS(NY)2.23
Fwd EY4.37%
FCF(TTM)1.43
FCFY2.8%
OCF(TTM)1.59
OCFY3.13%
SpS7.77
BVpS12.85
TBVpS4.45
PEG (NY)5.13
PEG (5Y)2.3
Graham Number23.87
Profitability
Industry RankSector Rank
ROA 3.17%
ROE 3.98%
ROCE 11.53%
ROIC 9.52%
ROICexc 10.26%
ROICexgc 25.36%
OM 22.59%
PM (TTM) 6.58%
GM 66.6%
FCFM 18.35%
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
ROICexc(3y)9.68%
ROICexc(5y)10.59%
ROICexgc(3y)24.93%
ROICexgc(5y)34.08%
ROCE(3y)10.9%
ROCE(5y)11.68%
ROICexgc growth 3Y-19.18%
ROICexgc growth 5Y-3.96%
ROICexc growth 3Y-9.13%
ROICexc growth 5Y5.53%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
F-Score8
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 1.17
Debt/EBITDA 0.69
Cap/Depr 25.35%
Cap/Sales 2.16%
Interest Coverage 15.32
Cash Conversion 65.89%
Profit Quality 278.92%
Current Ratio 4.54
Quick Ratio 3.08
Altman-Z 11.36
F-Score8
WACC10.95%
ROIC/WACC0.87
Cap/Depr(3y)40.04%
Cap/Depr(5y)43.01%
Cap/Sales(3y)3.78%
Cap/Sales(5y)4.03%
Profit Quality(3y)188.66%
Profit Quality(5y)177.71%
High Growth Momentum
Growth
EPS 1Y (TTM)8.84%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%9.52%
EPS Next Y5.04%
EPS Next 2Y7.37%
EPS Next 3Y10.09%
EPS Next 5Y8.61%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%0.24%
Revenue Next Year0.73%
Revenue Next 2Y3.52%
Revenue Next 3Y5.54%
Revenue Next 5Y7.1%
EBIT growth 1Y9.53%
EBIT growth 3Y-3.81%
EBIT growth 5Y11.98%
EBIT Next Year16.56%
EBIT Next 3Y11.92%
EBIT Next 5Y8.56%
FCF growth 1Y-1.07%
FCF growth 3Y-2.92%
FCF growth 5Y10.82%
OCF growth 1Y-9.8%
OCF growth 3Y-4.03%
OCF growth 5Y6.98%

BIO-TECHNE CORP / TECH Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BIO-TECHNE CORP?

ChartMill assigns a fundamental rating of 6 / 10 to TECH.


What is the valuation status of BIO-TECHNE CORP (TECH) stock?

ChartMill assigns a valuation rating of 4 / 10 to BIO-TECHNE CORP (TECH). This can be considered as Fairly Valued.


How profitable is BIO-TECHNE CORP (TECH) stock?

BIO-TECHNE CORP (TECH) has a profitability rating of 7 / 10.


What is the financial health of BIO-TECHNE CORP (TECH) stock?

The financial health rating of BIO-TECHNE CORP (TECH) is 8 / 10.


Is the dividend of BIO-TECHNE CORP sustainable?

The dividend rating of BIO-TECHNE CORP (TECH) is 4 / 10 and the dividend payout ratio is 62.38%.